Evaluating the Impact of Castration on Canine Prostate Disease Treatment: A Comprehensive Analysis Using Ultrasound Imaging
Abstract
The purpose of this study is to evaluate the outcome of castration, determine castration's influence on prostate disease, and whether castration influences the incidence of prostate neoplasia in dogs. Additionally, to investigate potential risk factors that may relate to canine prostatic disease. The study was conducted at the small animal clinic in kaunas from September 2022 to March 2024. 175 dogs were included in the study, they were further divided by potential risk factors (age, weight, breed group). To analyze the prevalence of prostatic disease at a veterinary clinic, data was collected from the participants and divided into categories depending on the primary cause of the visit. Ultrasound examination was performed in all study subjects twice, first before treatment and the second time 4 weeks after treatment. Changes before and after treatment were analyzed. A majority of canine prostate disease is treated by castration, however, during follow-up 2 patients developed carcinoma and prostate intraepithelial neoplasia (PIN). The factors of age group significantly increase the risk of prostate disease. Symptoms of prostatic disease vary depending on factors such as breed and weight (P < 0.05, P = 0.018, respectively), and most veterinary visits were due to constipation, and vomiting. After evaluation changes in prostate post-operation revealed a 39.97% decrease in prostate volume, Symptoms subsided, and the prostate returned to a homogenous state, with lesions…
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.